The global urinary incontinence market size is expected to reach USD 4.53 billion by 2028 with a CAGR of 7.6% during the forecast period, according to the latest report by Reports and Data. The increasing incidence of urinary incontinence (UI) in women worldwide, technological advances in urinary incontinence devices, improved health policies and insurance coverage, and the Growing patient awareness about the severity of the condition are key factors that are expected to drive the market revenue growth over the forecast period. Additionally, the development of advanced surgical and non-invasive therapies, the availability of a wide range of treatment modalities for urinary incontinence, and the growing number of user interface awareness initiatives are other key factors that are expected to further fuel market revenue growth in the future. .
Urinary incontinence is a common and distressing medical condition and is defined as involuntary or abnormal loss of urine caused by lower urinary tract dysfunction, chronic diseases or medications. Urinary incontinence can have serious negative effects on patients’ physical function, psychological health and quality of life. It can limit patient mobility and social interaction and can lead to depression in severe cases. Neglected urinary incontinence can lead to systemic infections, skin problems, and skin sores, adding yet further physical morbidity to patients who are already suffering from numerous symptoms. Urinary incontinence is recognized as a priority health problem by the World Health Organization and has highlighted the need for appropriate attention from all health care providers to develop effective management techniques. ‘urinary incontinence. It also places a significant economic burden on the individual and the healthcare system, which has further spurred demand for robust treatment options, user interface specific tools to improve patient outcomes and the introduction of advanced surgical interventions. This, in turn, can fuel market revenue growth in the future.
Incontinence treatment can vary depending on the type of incontinence, making it important to accurately identify the specific type of incontinence. Urinary incontinence is classified into three main types: stress UI, urge UI, and mixed UI. In recent years, treatment options for stress and urge urinary incontinence have advanced and aim to prevent the involuntary loss of urine caused by increased intra-abdominal pressure that occurs during physical activity. Advancements and rapid adoption of non-surgical therapies such as behavioral therapy and drug therapy are other factors that are expected to boost the market growth. However, lack of awareness about available treatment modalities, lack of favorable reimbursement policies in developing countries, and social stigma surrounding this condition are key factors that can hinder the growth of the market to some extent.
Get a sample report @ https://www.reportsanddata.com/sample-enquiry-form/2741
The global urinary incontinence market has grown significantly over the past few years and is expected to register rapid growth during the forecast period of 2021 to 2028. The pharmaceutical and healthcare sector is rapidly changing with technological innovations, the increasing health spending and improving health facilities and systems. . Many hospitals, outpatient surgical centers and clinics around the world are adopting state-of-the-art devices and equipment. The revenue growth of the global urinary incontinence market is highly influenced by factors such as increasing prevalence of chronic diseases, rapid advancements in healthcare and medical sector, high adoption of latest tools and techniques and the growth of funds by several public and private sectors. In addition, increasing attention to drug development, increasing demand for precision medicine, high adoption of home care settings and point-of-care diagnostics, increasing investment in research activities and development are expected to drive the revenue growth of the global market over the forecast period.
The ongoing pandemic is significantly changing the dynamics of the pharmaceutical and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, health devices in hospitals. This is expected to open up lucrative growth opportunities for market players in the coming years.
Key Companies Featured in the Report:
Covidien plc (Medtronic), Coloplast, Boston Scientific Corporation, CR Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc., Cook Medical, Prosurg, Inc. and Cogentix Medical Inc.
To learn more about the report, visit @ https://www.reportsanddata.com/report-detail/urinary-incontinence-market
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, licensing agreements, partnerships, mergers and acquisitions, collaborations and joint ventures to gain a strong foothold in the market.
Urinary Incontinence Market Segmentation:
Type Outlook (Revenue, USD billion, 2018-2028)
- Urge incontinence
- Overflow Incontinence
- Stress incontinence
- Functional incontinence
- Mixed urinary incontinence
- Total Incontinence
Devices Outlook (Revenue, USD Billion; 2018-2028)
- Electrical stimulation devices
- Not implantable
- Urethral bulking agents
- Urinary catheters
- Antimicrobial Foley Catheters
- Neuromodulation devices
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Ambulatory surgery centers
- home use
Download the summary @ https://www.reportsanddata.com/download-summary-form/2741
Regional outlook of the global urinary incontinence market
- North America
- Asia Pacific
- Rest of Asia-Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East and Africa
Request report customization @ https://www.reportsanddata.com/request-customization-form/2741
Thanks for reading the research report on the Global Urinary Incontinence Market. Please contact us to learn more about the personalization feature and our team will suggest the report that best suits your needs.
About reports and data
Reports and Data is a market research and consulting firm that provides syndicated research reports, custom research reports and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries, and helping customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including healthcare, touchpoints, chemicals, commodities and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Reports and Data has a strong base of experienced analysts in various areas of expertise. Our industry experience and ability to develop a workable solution to any research problem gives our clients the ability to secure an edge over their respective competitors.
Business Development Manager
Reports and data | Web: www.reportsanddata.com
Direct line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs